CIK: 0001792126 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 17, 2021
Total Value ($000): $1,189,867 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 3,156,981 | $172,624 | 14.5% | $39.31 | +52.2% | COM | 00166B105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,743,875 | $104,754 | 8.8% | $46.89 | -39.3% | COM | 68062P106 |
| DSGN | DESIGN THERAPEUTICS INC | 2,732,501 | $54,349 | 4.6% | $31.14 | -19.0% | COM | 25056L103 |
| — | VERVE THERAPEUTICS INC | 758,265 | $45,685 | 3.8% | $60.25 | — | COM | 92539P101 |
| DYN | DYNE THERAPEUTICS INC | 2,054,392 | $43,224 | 3.6% | $20.66 | -9.0% | COM | 26818M108 |
| — | DECIPHERA PHARMACEUTICALS IN | 1,100,000 | $40,271 | 3.4% | $37.07 | — | COM | 24344T101 |
| — | KARUNA THERAPEUTICS INC | 325,000 | $37,047 | 3.1% | $110.95 | — | COM | 48576A100 |
| — | GRAPHITE BIO INC | 1,070,762 | $32,905 | 2.8% | $30.73 | — | COM | 38870X104 |
| — | INSTIL BIO INC | 1,696,850 | $32,783 | 2.8% | $25.08 | — | COM | 45783C101 |
| CMPS | COMPASS PATHWAYS PLC | 850,000 | $32,428 | 2.7% | $37.19 | — | SPONSORED ADS | 20451W101 |
| NKTX | NKARTA INC | 1,002,382 | $31,765 | 2.7% | $29.47 | -2.2% | COM | 65487U108 |
| — | TURNING POINT THERAPEUTICS I | 400,000 | $31,208 | 2.6% | $83.82 | — | COM | 90041T108 |
| — | KINNATE BIOPHARMA INC | 1,329,602 | $30,953 | 2.6% | $32.51 | — | COM | 49705R105 |
| — | FORMA THERAPEUTICS HLDGS INC | 1,215,000 | $30,241 | 2.5% | $44.61 | — | SHS | 34633R104 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,125,000 | $29,273 | 2.5% | $25.99 | 0.0% | COM | 462260100 |
| IPSC | CENTURY THERAPEUTICS INC | 989,095 | $29,020 | 2.4% | $25.37 | 0.0% | COM | 15673T100 |
| CYTK | CYTOKINETICS INC | 1,400,000 | $27,706 | 2.3% | $22.42 | +4.7% | COM NEW | 23282W605 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,231,812 | $26,275 | 2.2% | $31.70 | -13.8% | COM | 28036F105 |
| — | RAPT THERAPEUTICS INC | 750,000 | $23,843 | 2.0% | $31.79 | — | Call | 75382E109 |
| APLS | APELLIS PHARMACEUTICALS INC | 350,000 | $22,120 | 1.9% | $51.60 | 0.0% | COM | 03753U106 |
| BCYC | BICYCLE THERAPEUTICS PLC | 715,000 | $21,707 | 1.8% | $29.87 | — | SPONSORED ADS | 088786108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 939,545 | $20,867 | 1.8% | $22.21 | — | SPONSORED ADS | 152309100 |
| BMEA | BIOMEA FUSION INC | 1,162,320 | $18,144 | 1.5% | $17.65 | 0.0% | COM | 09077A106 |
| — | IVERIC BIO INC | 2,500,000 | $15,775 | 1.3% | $6.25 | — | COM | 46583P102 |
| GHRS | GH RESEARCH PLC | 724,333 | $15,740 | 1.3% | $20.43 | 0.0% | ORDINARY SHARES | G3855L106 |
| — | ATHIRA PHARMA INC | 1,410,812 | $14,447 | 1.2% | $16.13 | — | COM | 04746L104 |
| JANX | JANUX THERAPEUTICS INC | 547,122 | $13,651 | 1.1% | $22.27 | 0.0% | COM | 47103J105 |
| — | KEZAR LIFE SCIENCES INC | 2,300,000 | $12,489 | 1.0% | $5.61 | — | COM | 49372L100 |
| — | RAIN THERAPEUTICS INC | 780,331 | $12,126 | 1.0% | $15.54 | — | COM | 75082Q105 |
| ACRS | ACLARIS THERAPEUTICS INC | 675,000 | $11,853 | 1.0% | $22.72 | 0.0% | COM | 00461U105 |
| COGT | COGENT BIOSCIENCES INC | 1,420,500 | $11,520 | 1.0% | $10.99 | -23.1% | COM | 19240Q201 |
| PRLD | PRELUDE THERAPEUTICS INC | 400,000 | $11,452 | 1.0% | $35.61 | 0.0% | COM | 74065P101 |
| — | KINIKSA PHARMACEUTICALS LTD | 800,000 | $11,144 | 0.9% | $16.22 | — | COM CL A | G5269C101 |
| — | HARPOON THERAPEUTICS INC | 800,000 | $11,096 | 0.9% | $16.51 | — | COM | 41358P106 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,339,793 | $10,598 | 0.9% | $10.38 | -9.1% | COM | 28617K101 |
| — | LANDOS BIOPHARMA INC | 899,106 | $10,385 | 0.9% | $9.98 | — | COM | 515069102 |
| — | REPARE THERAPEUTICS INC | 330,000 | $10,289 | 0.9% | $30.58 | — | COM | 760273102 |
| — | RAPT THERAPEUTICS INC | 270,000 | $8,583 | 0.7% | $31.79 | — | COM | 75382E109 |
| — | TALARIS THERAPEUTICS INC | 507,923 | $7,461 | 0.6% | $14.69 | — | COM | 87410C104 |
| CGEM | CULLINAN ONCOLOGY INC | 288,458 | $7,428 | 0.6% | $40.60 | -24.2% | COM | 230031106 |
| PMVP | PMV PHARMACEUTICALS INC | 206,564 | $7,056 | 0.6% | $37.96 | -12.0% | COM | 69353Y103 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 300,000 | $6,810 | 0.6% | $20.37 | 0.0% | COM | 61225M102 |
| — | CATABASIS PHARMACEUTICALS IN | 3,190,000 | $6,731 | 0.6% | $2.11 | — | COM NEW | 14875P206 |
| — | ASLAN PHARMACEUTICALS LTD | 2,000,000 | $6,600 | 0.6% | $3.35 | — | ADS | 04522R101 |
| — | ALIGOS THERAPEUTICS INC | 212,785 | $4,339 | 0.4% | $27.65 | — | COM | 01626L105 |
| CCCC | C4 THERAPEUTICS INC | 112,928 | $4,273 | 0.4% | $29.00 | +23.5% | COM STK | 12529R107 |
| — | IKENA ONCOLOGY INC | 299,853 | $4,210 | 0.4% | $28.25 | — | COM | 45175G108 |
| ANNX | ANNEXON INC | 159,622 | $3,593 | 0.3% | $23.46 | -5.6% | COM | 03589W102 |
| — | BCTG ACQUISITION CORP | 200,000 | $2,276 | 0.2% | $10.36 | — | COM | 05492W103 |
| — | ARYA SCIENCES ACQU CORP IV | 200,000 | $2,144 | 0.2% | $10.47 | — | CL A | G31659108 |
| — | PASSAGE BIO INC | 125,010 | $1,655 | 0.1% | $14.85 | — | COM | 702712100 |
| — | FS DEVELOPMENT CORP II | 123,543 | $1,233 | 0.1% | $9.96 | — | COM CL A | 30318F100 |
| — | HEALTH SCIENCES ACQ CORP 2 | 100,000 | $1,020 | 0.1% | $11.00 | — | ORD SHS | G4411D109 |
| — | RESEARCH ALLIANCE CORP II | 100,000 | $1,014 | 0.1% | $10.25 | — | COM CL A | 760873109 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 37,069 | $844 | 0.1% | $20.76 | 0.0% | COM | 23954D109 |
| MLTX | HELIX ACQUISITION CORP | 50,000 | $518 | 0.0% | $11.37 | — | COM CL A | G4444C102 |
| — | NUVATION BIO INC | 66,666 | $173 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |
| MREO | MEREO BIOPHARMA GROUP PLC | 46,984 | $149 | 0.0% | $3.17 | — | ADS | 589492107 |